Upadacitinib is safe and effective for treatment of non-radiographic axial spondyloarthritis

Quality-of-life measures and subjective back pain were improved with upadacitinib. Evidence Rating Level: 1 (Excellent) Study Rundown: First-line …
Source: back pain